the actuarial survival for all patients was 53 % at 6 years , with 79 % survival for nonsevere aplastic anemia ( nsaa ) and 36 % for severe aplastic anemia ( saa ) .
C0002874
aplastic anemia
C1883018
severe aplastic anemia